| Nombre del producto |
Idarubicin HCl |
| Sinónimos |
Idarubicin Hydrochloride; (1S,3S)-3-acetyl-3,5,12-trihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxyhexopyranoside hydrochloride (1:1); (1S,3S)-3-acetyl-3,5,12-trihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside hydrochloride (1:1); (7S-cis)-9-acetyl-7-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxynaphthacene-5,12-dione hydrochloride |
| Fórmula molecular |
C26H28ClNO9 |
| Peso Molecular |
533.9548 |
| InChI |
InChI=1/C26H27NO9.ClH/c1-10-21(29)15(27)7-17(35-10)36-16-9-26(34,11(2)28)8-14-18(16)25(33)20-19(24(14)32)22(30)12-5-3-4-6-13(12)23(20)31;/h3-6,10,15-17,21,29,32-34H,7-9,27H2,1-2H3;1H/t10-,15-,16-,17-,21+,26-;/m0./s1 |
| Número de registro CAS |
57852-57-0 |
| EINECS |
260-990-7 |
| Estructura Molecular |
|
| Punto de ebullición |
725.4°C at 760 mmHg |
| Punto de inflamación |
392.5°C |
| SÃmbolos de Peligro |
 T+:Very toxic;
|
| Códigos de Riesgos |
R60:;
R61:;
R28:;
R40:;
|
| Descripción de Seguridad |
S53:;
S45:;
|
|
